Leukemia & Lymphoma Society, The
Registered Principal Details
Business Or Interest:
To cure leukemia, lymphoma, Hodgkins disease and myeloma, and to improve the quality of life of patients and their families.
Lobbying Interests:
Health care policy, particularly as it relates to cancers.
Title:
National Director - State Affairs
To cure leukemia, lymphoma, Hodgkins disease and myeloma, and to improve the quality of life of patients and their families.
Lobbying Interests:
Health care policy, particularly as it relates to cancers.
Title:
National Director - State Affairs
Contact
LN
Lisa Nelson
750 First St., Suite 700
Washington, DC 20002
(540) 722-2726
Lisa.Nelson@lls.org
http://www.leukemia-lymphoma.org
750 First St., Suite 700
Washington, DC 20002
(540) 722-2726
Lisa.Nelson@lls.org
http://www.leukemia-lymphoma.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| John Keckhaver | Exclusive Duties N/A | Authorized On 1/9/2013 | Withdrawn On 2/12/2014 |
| Christina Lee | Exclusive Duties N/A | Authorized On 5/8/2013 | Withdrawn On N/A |
| AnnMarie Frakes | Exclusive Duties N/A | Authorized On 5/8/2013 | Withdrawn On N/A |
| Dee George | Exclusive Duties N/A | Authorized On 2/27/2014 | Withdrawn On 9/2/2014 |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 392
Toggle details
Assembly Bill 392
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
9/30/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
For
Notification Date9/30/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 300
Toggle details
Senate Bill 300
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
2013 Wisconsin Act 186
9/25/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
2013 Wisconsin Act 186
For
Notification Date9/25/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Issues surrounding health insurance plan disparate coverage of self-prescribed anti-cancer medications and traditional intravenous anti-cancer medications.
Development, drafting or introduction of a proposal relating to
Issues surrounding health insurance plan disparate coverage of self-prescribed anti-cancer medications and traditional intravenous anti-cancer medications.
Issues surrounding health insurance plan disparate coverage of self-prescribed anti-cancer medications and traditional intravenous anti-cancer medications.
Action Intended To Affect
Legislative matter
Notification Date
2/1/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
2/1/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2013 January - June $19,818.54 |
2013 July - December $30,459.30 |
2014 January - June $19,686.81 |
2014 July - December $338.00 |
Total $70,302.66 |
| Total Hours Communicating | 2013 January - June 23.00 |
2013 July - December 75.25 |
2014 January - June 17.00 |
2014 July - December 1.00 |
Total 116.25 |
| Total Hours Other | 2013 January - June 87.25 |
2013 July - December 53.50 |
2014 January - June 71.00 |
2014 July - December 3.00 |
Total 214.75 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December 50% |
2014 January - June 50% |
2014 July - December 50% |
Total 33% |
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December 50% |
2014 January - June 50% |
2014 July - December 50% |
Total 33% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Issues surrounding health insurance plan disparate coverage of self-prescribed anti-cancer medications and traditional intravenous anti-cancer medications.
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June 100% |
2013 July - December |
2014 January - June |
2014 July - December |
Total 33% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.